Heat thErapy And mobiLity in COVID-19 Survivors
Physical Rehabilitation of Long COVID by Heat Therapy
- Long COVID
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- University of Nebraska
- Enrolment target
- 99
- Started
- 16 January 2025
- Main results due
- 31 August 2028
- Study sites
- 1
- Registry updated
- 28 September 2026
Can you take part?
- Ages 50 years to 90 years.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Between the ages of 50 and 90 years * Free from orthopedic limitations that would prohibit performing leg exercise * BMI \< 40 kg/m2 and weigh \< 400lbs * Previously contracted Covid-19 and have persistent symptoms such as a fatigue or decline in physical function, for at least 2 months following SARS-CoV-2 infection Exclusion Criteria: * Unable to give written informed consent * Women who are pregnant, breastfeeding, or likely to become pregnant within the next 6 months * Claustrophobia * Orthopedic limitations that would prohibit them from walking * Currently enrolled in an exercise-based or respiratory muscle rehabilitation program.
What this study is about
In the sponsor’s own words, from the registry.
Post-acute sequelae of SARS-CoV-2 infection (PASC) is becoming a major risk factor for chronic diseases, with older adults and those with underlying health conditions at risk of developing persistent mobility limitations and disabilities. Although exercise intervention is a common strategy to restore functional capacity, it may not be feasible or enticing to many people with PASC. This clinical trial seeks to establish the tolerability and efficacy of at home lower-body heat therapy for improving functional capacity along with metabolic and vascular health in late-middle aged and older adults with PASC, also known as "long COVID".
Study sites(1)
University of Nebraska Omaha
Omaha, Nebraska, United States
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT06928116. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me